Analyst Ratings For NASDAQ:NUVA – NuVasive (NASDAQ:NUVA)
Today, Needham & Company LLC reiterated its Buy rating on NASDAQ:NUVA – NuVasive (NASDAQ:NUVA) with a price target of $69.00.
Some recent analyst ratings include
- 5/2/2018-Needham & Company LLC Reiterated Rating of Buy .
- 5/2/2018-BMO Capital Markets was Downgraded by analysts at BMO Capital Markets from a “Outperform ” rating to a ” Market Perform” rating. They now have a $69.00 price target on the stock.
- 5/2/2018-BTIG Research Reiterated Rating of Buy.
- 4/4/2018-Goldman Sachs initiated coverage with a Neutral rating.
- 2/27/2018-Robert W. Baird Reiterated Rating of Hold.
- 2/27/2018-Barclays Reiterated Rating of Overweight .
- On 3/6/2018 Gregory T Lucier, CEO, bought 6,000 with an average share price of $50.30 per share and the total transaction amounting to $301,800.00.
- On 3/1/2018 Gregory T Lucier, CEO, bought 6,000 with an average share price of $48.57 per share and the total transaction amounting to $291,420.00.
- On 8/29/2017 Gregory T Lucier, CEO, bought 2,000 with an average share price of $61.52 per share and the total transaction amounting to $123,040.00.
- On 8/18/2017 Lesley H. Howe, Director, sold 3,970 with an average share price of $64.64 per share and the total transaction amounting to $256,620.80.
- On 8/17/2017 Gregory T Lucier, CEO, bought 5,000 with an average share price of $66.22 per share and the total transaction amounting to $331,100.00.
- On 8/1/2017 Peter Michael Leddy, EVP, bought 7,850 with an average share price of $63.88 per share and the total transaction amounting to $501,458.00.
- On 3/8/2017 Jason Hannon, Insider, sold 24,840 with an average share price of $74.22 per share and the total transaction amounting to $1,843,624.80.
Recent Trading Activity for NASDAQ:NUVA – NuVasive (NASDAQ:NUVA)
Shares of NASDAQ:NUVA – NuVasive closed the previous trading session at 48.77 down -4.37 8.22% with shares trading hands.
